SkinBioTherapeutics PLC
LSE:SBTX
SkinBioTherapeutics PLC
LSE:SBTX
Price:
9.6
GBX
-8.57%
Market Cap:
£24.9m
Wall Street
Price Targets
SBTX Price Targets Summary
SkinBioTherapeutics PLC
SkinBioTherapeutics PLC
Wall Street analysts forecast SBTX stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for
SBTX
is 29.58 GBX
with a low forecast of 29.29 GBX and a high forecast of 30.45 GBX.
Lowest
Price Target
29.29
GBX
205% Upside
Average
Price Target
29.58
GBX
208% Upside
Highest
Price Target
30.45
GBX
217% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is SBTX's stock price target?
Price Target
29.58
GBX
29.58
GBX
According to Wall Street analysts, the average 1-year price target for
SBTX
is 29.58 GBX
with a low forecast of 29.29 GBX and a high forecast of 30.45 GBX.
What is SkinBioTherapeutics PLC's Revenue forecast?
Projected CAGR
34%
34%
The
compound annual growth rate
of SkinBioTherapeutics PLC's revenue for the next 2 years is
34%.
